Human β-defensin-2: A natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 1, 2007, Pages 15-22

  Soto, Eleazar ^a,b   Espinoza, Jimmy ^a,b,c   Nien, Jyh Kae ^a,b   Kusanovic, Juan Pedro ^a,b   Erez, Offer ^a,b   Richani, Karina ^a,b   Santolaya Forgas, Joaquin ^a,b,c   Romero, Roberto ^a,b,d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b Department of Obstetrics and Gynecology ^*

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Amniotic fluid; Antimicrobial peptide; Human beta defensin 2; Intra amniotic infection; Preterm labor; Preterm PROM

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN ANTIBODY; POLYCLONAL ANTIBODY; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; BETA DEFENSIN; DEFB4 PROTEIN, HUMAN;

ADULT; AMNIOCENTESIS; AMNION FLUID; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BACTERIUM CULTURE; CANDIDA ALBICANS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNE RESPONSE; LABOR; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; NONHUMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SECOND TRIMESTER PREGNANCY; STATISTICAL SIGNIFICANCE; CROSS-SECTIONAL STUDY; GESTATIONAL AGE; IMMUNOLOGY; INFECTION; METABOLISM; MICROBIOLOGY; PREGNANCY;

ADULT; AMNIOTIC FLUID; BETA-DEFENSINS; CROSS-SECTIONAL STUDIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFECTION; OBSTETRIC LABOR, PREMATURE; PREGNANCY;

EID: 34248580011     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050601036212     Document Type: Article

References (75)

1. Slattery MM, Morrison JJ. Preterm delivery. Lancet 2002;360:1489-1497.
2. Romero R, Espinoza J, Mazor M, Chaiworapongsa T. The preterm parturition syndrome. In: Gitchley H, Bennett P, Thornton S, editors. Preterm Births. London: RCOG Press; 2004. pp 28-60.
3. Mathews TJ, Menacker F, MacDorman MF. Infant mortality statistics from the 2002 period: Linked birth/infant death data set. Natl Vital Stat Rep 2004;53:1-29.
4. Tucker J, McGuire W. Epidemiology of preterm birth. BMJ 2004;329:675-678.
5. Romero R, Gomez R, Araneda H, Ramirez M, Cotton DB. Cervical mucus inhibits microbial growth: A host defense mechanism to prevent ascending infection in pregnant and non-pregnant women. Am J Obstet Gynecol 1993;168:312.
6. Eggert-Kruse W, Botz I, Pohl S, Rohr G, Strowitzki T. Antimicrobial activity of human cervical mucus. Hum Reprod 2000;15:778-784.
7. Hein M, Helmig RB, Schonheyder HC, Ganz T, Uldbjerg N. An in vitro study of antibacterial properties of the cervical mucus plug in pregnancy. Am J Obstet Gynecol 2001;185:586-592.
8. Hein M, Valore EV, Helmig RB, Uldbjerg N, Ganz T. Antimicrobial factors in the cervical mucus plug. Am J Obstet Gynecol 2002;187:137-144.
9. Talmi YP, Sigler L, Inge E, Finkelstein Y, Zohar Y. Antibacterial properties of human amniotic membranes. Placenta 1991;12:285-288.
10. Kjaergaard N, Hein M, Hyttel L, Helmig RB, Schonheyder HC, Uldbjerg N, Madsen H. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol 2001;94:224-229.
11. Svinarich DM, Gomez R, Romero R. Detection of human defensins in the placenta. Am J Reprod Immunol 1997;38:252-255.
12. Guleria I, Pollard JW. The trophoblast is a component of the innate immune system during pregnancy. Nat Med 2000;6:589-593.
13. Galask RP, Snyder IS. Antimicrobial factors in amniotic fluid. Am J Obstet Gynecol 1970;106:59-65.
14. Thadepalli H, Appleman MD, Maidman JE, Arce JJ, Davidson EC Jr. Antimicrobial effect of amniotic fluid against anaerobic bacteria. Am J Obstet Gynecol 1977;127:250-254.
15. Tafari N, Ross SM, Naeye RL, Galask RP, Zaar B. Failure of bacterial growth inhibition by amniotic fluid. Am J Obstet Gynecol 1977;128:187-189.
16. Thadepalli H, Bach VT, Davidson EC Jr. Antimicrobial effect of amniotic fluid. Obstet Gynecol 1978;52:198-204.
17. Appelbaum PC, Shulman G, Chambers NL, Simon NV, Granados JL, Fairbrother PF, Naeye RL. Studies on the growth-inhibiting property of amniotic fluids from two United States population groups. Am J Obstet Gynecol 1980;137:579-582.
18. Thadepalli H, Gangopadhyay PK, Maidman JE. Amniotic fluid analysis for antimicrobial factors. Int J Gynaecol Obstet 1982;20:65-72.
19. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-395.
20. Ganz T. Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol 2003;3:710-720.
21. Tosi MF. Innate immune responses to infection. J Allergy Clin Immunol 2005;116:241-249.
22. Weiss J, Elsbach P, Olsson I, Odeberg H. Purification and characterization of a potent bactericidal and membrane active protein from the granules of human polymorphonuclear leukocytes. J Biol Chem 1978;253:2664-2672.
23. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF, Lehrer RI. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985;76:1427-1435.
24. Jones DE, Bevins CL. Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 1992;267:23216-23225.
25. Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996;396:319-322.
26. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000;1:141-150.
27. Espinoza J, Chaiworapongsa T, Romero R, Edwin S, Rathnasabapathy C, Gomez R, Bujold E, Camacho N, Kim YM, Hassan S, et al. Antimicrobial peptides in amniotic fluid: Defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med 2003;13:2-21.
28. Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC. Human defensins. J Mol Med 2005;83:587-595.
29. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin. Nature 1997;387:861.
30. Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 2001;117:106-111.
31. Dorschner RA, Lin KH, Murakami M, Gallo RL. Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: Innate immunity during development of the adaptive response. Pediatr Res 2003;53:566-572.
32. Mathews M, Jia HP, Guthmiller JM, Losh G, Graham S, Johnson GK, Tack BF, McCray PB, Jr. Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun 1999;67:2740-2745.
33. Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998;102:874-880.
34. Hiratsuka T, Nakazato M, Date Y, Ashitani J, Minematsu T, Chino N, Matsukura S. Identification of human beta-defensin-2 in respiratory tract and plasma and its increase in bacterial pneumonia. Biochem Biophys Res Commun 1998;249:943-947.
35. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, Greenberg EP, Valore EV, Welsh MJ, Ganz T, et al. Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci USA 1998;95:14961-14966.
36. Nitschke M, Wiehl S, Baer PC, Kreft B. Bactericidal activity of renal tubular cells: The putative role of human betadefensins. Exp Nephrol 2002;10:332-337.
37. Joly S, Maze C, McCray PB Jr, Guthmiller JM. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 2004;42:1024-1029.
38. Feng Z, Jiang B, Chandra J, Ghannoum M, Nelson S, Weinberg A. Human beta-defensins: Differential activity against candidal species and regulation by Candida albicans. J Dent Res 2005;84:445-450.
39. Heine RP, Wiesenfeld H, Mortimer L, Greig PC. Amniotic fluid defensins: Potential markers of subclinical intrauterine infection. Clin Infect Dis 1998;27:513-518.
40. Yoshio H, Tollin M, Gudmundsson GH, Lagercrantz H, Jornvall H, Marchini G, Agerberth B. Antimicrobial polypeptides of human vernix caseosa and amniotic fluid: Implications for newborn innate defense. Pediatr Res 2003;53:211-216.
41. Akinbi HT, Narendran V, Pass AK, Markart P, Hoath SB. Host defense proteins in vernix caseosa and amniotic fluid. Am J Obstet Gynecol 2004;191:2090-2096.
42. Marinoni E, Di Iorio R, Letizia C, Villaccio B, Alberini A, Cosmi EV. Amniotic fluid concentrations of adrenomedullin in preterm labor. Obstet Gynecol 1999;93:964-967.
43. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996;87:163-168.
44. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995;32:982-986.
45. Schonwetter BS, Stolzenberg ED, Zasloff MA. Epithelial antibiotics induced at sites of inflammation. Science 1995; 267:1645-1648.
46. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG. hBD-1: A novel beta-defensin from human plasma. FEBS Lett 1995;368:331-335.
47. Quinones-Mateu ME, Lederman MM, Feng Z, Chakraborty B, Weber J, Rangel HR, Marotta ML, Mirza M, Jiang B, Kiser P, et al. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 2003;17:F39-F48.
48. Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: Review and significance for oral applications. Crit Rev Oral Biol Med 1998;9:399-414.
49. Bierbaum G, Sahl HG. Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes. Arch Microbiol 1985;141:249-254.
50. Yang L, Weiss TM, Lehrer RI, Huang HW. Crystallization of antimicrobial pores in membranes: Magainin and protegrin. Biophys J 2000;79:2002-2009.
51. Westerhoff HV, Juretic D, Hendler RW, Zasloff M. Magainins and the disruption of membrane-linked free-energy transduction. Proc Natl Acad Sci USA 1989;86:6597-6601.
52. Hoover DM, Rajashankar KR, Blumenthal R, Puri A, Oppenheim JJ, Chertov O, Lubkowski J. The structure of human beta-defensin-2 shows evidence of higher order oligomerization. J Biol Chem 2000;275:32911-32918.
53. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001;276:5707-5713.
54. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schroder JM, Wang JM, Howard OM, et al. Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-528.
55. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Faber JM, Segal DM, Oppenheim JJ, et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002;298:1025-1029.
56. Niyonsaba F, Ogawa H, Nagaoka I. Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. Immunology 2004;111:273-281.
57. McDermott AM, Redfern RL, Zhang B, Pei Y, Huang L, Proske RJ. Defensin expression by the cornea: Multiple signalling pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal epithelial cells. Invest Ophthalmol Vis Sci 2003;44:1859-1865.
58. Liu L, Roberts AA, Ganz T. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 2003;170:575-580.
59. Harder J, Meyer-Hoffert U, Wehkamp K, Schwichtenberg L, Schroder JM. Differential gene induction of human beta-defensins (hBD-1, -2, -3, and -4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 2004;123:522-529.
60. Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, Schroder JM. Mucoid Pseudomonas aeruginosa, TNF-alpha, and IL-1beta, but not IL-6, induce human beta-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000;22:714-721.
61. Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262-3269.
62. Feng Y, Pan X, Huang N, Feng Y, Wu Q, Wang B. [The human beta-defensins expression in female genital tract and pregnancy-related tissues.] Sichuan Da Xue Xue Bao Yi Xue Ban 2003;34:217-219.
63. Otsuki K, Yoda A, Saito H, Mitsuhashi Y, Toma Y, Shimizu Y, Yanaihara T. Amniotic fluid lactoferrin in intrauterine infection. Placenta 1999;20:175-179.
64. Pacora P, Maymon E, Gervasi MT, Gomez R, Edwin SS, Yoon BH, Romero R. Lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes. Am J Obstet Gynecol 2000;183:904-910.
65. Cherry SH, Filler M, Harvey H. Lysozyme content of amniotic fluid. Am J Obstet Gynecol 1973;116:639-642.
66. Ford LC, DeLange RJ, Lebherz TB. Identification of a bactericidal factor (B-lysin) in amniotic fluid at 14 and 40 weeks' gestation. Am J Obstet Gynecol 1977;127:788-792.
67. Hisanaga S, Umezu T, Shimokawa H, Maesato S. Amniotic fluid lysozyme content in normal and abnormal pregnancy. Nippon Sanka Fujinka Gakkai Zasshi 1982;34:541-544.
68. Evaldson G, Malmborg AS, Nord CE, Ostensson K. Bacteroides fragilis, Streptococcus intermedius and group B streptococci in ascending infection of pregnancy. An animal experimental study. Gynecol Obstet Invest 1983;15:230-241.
69. Galask RP, Varner MW, Petzold CR, Wilbur SL. Bacterial attachment to the chorioamniotic membranes. Am J Obstet Gynecol 1984;148:915-928.
70. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, McKaig R, Beck J. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996;67:1103-1113.
71. Jeffcoat MK, Geurs NC, Reddy MS, Cliver SP, Goldenberg RL, Hauth JC. Periodontal infection and preterm birth: Results of a prospective study. J Am Dent Assoc 2001;132:875-880.
72. Madianos PN, Lieff S, Murtha AP, Boggess KA, Auten RL Jr, Beck JD, Offenbacher S. Maternal periodontitis and prematurity. Part II: Maternal infection and fetal exposure. Ann Periodontol 2001;6:175-182.
73. Bearfield C, Davenport ES, Sivapathasundaram V, Allaker RP. Possible association between amniotic fluid microorganism infection and microflora in the mouth. BJOG 2002;109:527-533.
74. Dortbudak O, Eberhardt R, Ulm M, Persson GR. Periodontitis, a marker of risk in pregnancy for preterm birth. J Clin Periodontol 2005;32:45-52.
75. Boggess KA, Madianos PN, Preisser JS, Moise KJ Jr, Offenbacher S. Chronic maternal and fetal Porphyromonas gingivalis exposure during pregnancy in rabbits. Am J Obstet Gynecol 2005;192:554-557.